These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 38796327)
1. Regional differences in provider recommendation of HPV vaccines among 13-to-17 year old adolescents from 2019 to 2021. Lynette Ejezie C; Cuccaro P; Savas LS; Shegog R Vaccine; 2024 Aug; 42(20):125974. PubMed ID: 38796327 [TBL] [Abstract][Full Text] [Related]
2. Disparities in Provider Recommendation of Human Papillomavirus Vaccination for U.S. Adolescents. Mohammed KA; Geneus CJ; Osazuwa-Peters N; Adjei Boakye E; Tobo BB; Burroughs TE J Adolesc Health; 2016 Nov; 59(5):592-598. PubMed ID: 27506278 [TBL] [Abstract][Full Text] [Related]
3. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Ylitalo KR; Lee H; Mehta NK Am J Public Health; 2013 Jan; 103(1):164-9. PubMed ID: 22698055 [TBL] [Abstract][Full Text] [Related]
4. Correlates of HPV vaccine initiation and provider recommendation among male adolescents, 2014 NIS-Teen. Landis K; Bednarczyk RA; Gaydos LM Vaccine; 2018 Jun; 36(24):3498-3504. PubMed ID: 29752025 [TBL] [Abstract][Full Text] [Related]
5. Association of Provider Recommendation and Human Papillomavirus Vaccination Initiation among Male Adolescents Aged 13-17 Years-United States. Lu PJ; Yankey D; Fredua B; O'Halloran AC; Williams C; Markowitz LE; Elam-Evans LD J Pediatr; 2019 Mar; 206():33-41.e1. PubMed ID: 30448270 [TBL] [Abstract][Full Text] [Related]
6. Parent-reported provider recommendation of HPV vaccination among minority adolescents before and during the COVID-19 pandemic: Findings from the National Immunization Survey-Teen, 2019-2021. Ejezie CL; Cuccaro P; Durand C; Savas L; Shegog R Prev Med Rep; 2023 Oct; 35():102286. PubMed ID: 37361924 [TBL] [Abstract][Full Text] [Related]
7. Patient-Level Factors Associated With Lack of Health Care Provider Recommendation for the Human Papillomavirus Vaccine Among Young Cancer Survivors. York JM; Klosky JL; Chen Y; Connelly JA; Wasilewski-Masker K; Giuliano AR; Robison LL; Wong FL; Hudson MM; Bhatia S; Landier W J Clin Oncol; 2020 Sep; 38(25):2892-2901. PubMed ID: 32552278 [TBL] [Abstract][Full Text] [Related]
8. The prevalence of human papillomavirus vaccination among racial and ethnic minority adolescents during the COVID-19 pandemic. Ejezie CL; Savas LS; Durand C; Shegog R; Cuccaro P JNCI Cancer Spectr; 2023 Aug; 7(5):. PubMed ID: 37651597 [TBL] [Abstract][Full Text] [Related]
9. Variations in reason for intention not to vaccinate across time, region, and by race/ethnicity, NIS-Teen (2008-2016). Hirth JM; Fuchs EL; Chang M; Fernandez ME; Berenson AB Vaccine; 2019 Jan; 37(4):595-601. PubMed ID: 30580838 [TBL] [Abstract][Full Text] [Related]
10. Individual, systemic and state factors associated with provider recommendation of HPV vaccination: Findings from NIS-Teen, 2020. Osaghae I; Chandra M; Talluri R; Shete S Hum Vaccin Immunother; 2023 Aug; 19(2):2239678. PubMed ID: 37550623 [TBL] [Abstract][Full Text] [Related]
11. Parental intent to initiate and complete the human papillomavirus vaccine series in the USA: a nationwide, cross-sectional survey. Sonawane K; Zhu Y; Montealegre JR; Lairson DR; Bauer C; McGee LU; Giuliano AR; Deshmukh AA Lancet Public Health; 2020 Sep; 5(9):e484-e492. PubMed ID: 32707126 [TBL] [Abstract][Full Text] [Related]
12. Disparities in HPV Vaccination Among Adolescents by Health Care Facility Type. Nair M; Fokom Domgue J; Joseph CLM; Alleman ER; Williams AM; Abouelella DK; Babatunde OA; Osazuwa-Peters N; Adjei Boakye E JAMA Pediatr; 2024 Sep; 178(9):932-939. PubMed ID: 39073824 [TBL] [Abstract][Full Text] [Related]
13. Factors Associated With Parents' Intent to Vaccinate Adolescents for Human Papillomavirus: Findings From the 2014 National Immunization Survey-Teen. Mohammed KA; Vivian E; Loux TM; Arnold LD Prev Chronic Dis; 2017 Jun; 14():E45. PubMed ID: 28595031 [TBL] [Abstract][Full Text] [Related]
14. A Comparison of Parent- and Provider-Reported Human Papillomavirus Vaccination of Adolescents. Adjei Boakye E; Tobo BB; Osazuwa-Peters N; Mohammed KA; Geneus CJ; Schootman M Am J Prev Med; 2017 Jun; 52(6):742-752. PubMed ID: 27890518 [TBL] [Abstract][Full Text] [Related]
15. Race-specific trends in HPV vaccinations and provider recommendations: persistent disparities or social progress? Burdette AM; Webb NS; Hill TD; Jokinen-Gordon H Public Health; 2017 Jan; 142():167-176. PubMed ID: 27592005 [TBL] [Abstract][Full Text] [Related]
16. Predictors of provider recommendation for HPV vaccine among young adult men and women: findings from a cross-sectional survey. Gerend MA; Shepherd MA; Lustria ML; Shepherd JE Sex Transm Infect; 2016 Mar; 92(2):104-7. PubMed ID: 26297720 [TBL] [Abstract][Full Text] [Related]
17. Provider communication and HPV vaccination: The impact of recommendation quality. Gilkey MB; Calo WA; Moss JL; Shah PD; Marciniak MW; Brewer NT Vaccine; 2016 Feb; 34(9):1187-92. PubMed ID: 26812078 [TBL] [Abstract][Full Text] [Related]
18. Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health. Lau M; Lin H; Flores G Vaccine; 2012 Apr; 30(20):3112-8. PubMed ID: 22425179 [TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus Vaccination of Adolescents with Chronic Medical Conditions: A National Survey of Pediatric Subspecialists. Hofstetter AM; Lappetito L; Stockwell MS; Rosenthal SL J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):88-95. PubMed ID: 27542999 [TBL] [Abstract][Full Text] [Related]
20. Area-based socioeconomic factors and Human Papillomavirus (HPV) vaccination among teen boys in the United States. Henry KA; Swiecki-Sikora AL; Stroup AM; Warner EL; Kepka D BMC Public Health; 2017 Jul; 18(1):19. PubMed ID: 28709420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]